Tricida Inc (NASDAQ:TCDA) had a decrease of its short interest by 25.59%. It was announced in November by FINRA the 439,400 short interest on TCDA. The down change of 25.59% from 590,500 shares was reported. Tricida Inc (NASDAQ:TCDA) has 90,300 shares average volume. It’ll cost 5 days for TCDA to recover its previous position. Tricida Inc float short is 2.29%.
TCDA is reaching $29.72 during the last trading session, after increased 4.61%.Tricida, Inc. has volume of 102,280 shares. Since November 10, 2017 TCDA has 0.00% and is . The stock underperformed the S&P 500 by 15.62%.
Tricida, Inc., a late-stage pharmaceutical company, focuses on developing therapeutics to address renal, metabolic, and cardiovascular disease.The firm is worth $1.25 billion. The Company’s lead product candidate, TRC101, a non-absorbed orally-administered polymer drug that is in Phase III clinical trials used to treat metabolic acidosis in patients with chronic kidney disease.Last it reported negative earnings.
Another two news for Tricida, Inc. (NASDAQ:TCDA) were briefly published by: Streetinsider.com on November 08, 2018 with title “Tricida (TCDA) Tops Q3 EPS by 13c”. The other Benzinga.com‘s article was titled “The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results, Large-Cap Pharma Earnings …” and published on October 22, 2018.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.